AVTR Stock Outlook 2026: Avantor's Consumables Moat Meets a Deleveraging Bet
A frank 2026 analysis of Avantor (AVTR). We break down the spec-in consumables moat in bioprocessing and ultra-high-purity chemicals, the Lab Solutions distribution versus Bioscience Production split, post-destocking demand recovery, the leverage that shapes the story, cost-out execution, and how AVTR stacks up against Thermo, Danaher, Sartorius, and Repligen.
AVTR Avantor bioprocessing
